Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L.

Lung cysteine cathepsins B, K, L, and S contribute to physiological and pathological processes including degradation of antimicrobial peptides/proteins (AMPs) such as surfactant protein SP-A, lactoferrin, secretory leukocyte peptidase inhibitor, and beta-defensins-2 and -3. Substantial amounts of uncleaved LL-37, a 37-mer cationic AMP, were observed in the sputum of patients with cystic fibrosis (CF). Nevertheless LL-37 was degraded after prolonged incubation in CF sputum, and the hydrolysis was blocked by E-64, a selective inhibitor of cysteine proteases. Cathepsins K and S, expressed in human alveolar macrophages, thoroughly hydrolyzed LL-37 in vitro, whereas it competitively inhibited cathepsin L (Ki = 150 nM). Cleavage of LL-37 by cathepsins S and K impaired its antimicrobial activity against Pseudomonas aeruginosa and Staphylococcus aureus, in a time- and concentration-dependent manner. The exchange of residues 67 and 205 in the S2 pockets of cathepsins L (Leu67Tyr/Ala205Leu) and K (Tyr67Leu/Leu205Ala) switched the specificity of these mutants toward LL-37. Molecular modeling suggested that LL-37 interacted with the active site of cathepsin L in both forward (i.e., substrate-like) and reverse orientations with similar binding energies. Our data support the hypothesis that cysteine cathepsins modulate the innate immunity response by degrading distinct and representative members of the AMP family.

[1]  S. Marchand-Adam,et al.  Cysteine cathepsins and cystatins: from ancillary tasks to prominent status in lung diseases , 2015, Biological chemistry.

[2]  J. Potempa,et al.  Lack of cathelicidin processing in Papillon-Lefèvre syndrome patients reveals essential role of LL-37 in periodontal homeostasis , 2014, Orphanet Journal of Rare Diseases.

[3]  M. Fonović,et al.  Cysteine cathepsins and extracellular matrix degradation. , 2014, Biochimica et biophysica acta.

[4]  I. Oglesby,et al.  miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production. , 2014, American journal of respiratory and critical care medicine.

[5]  S. Marchand-Adam,et al.  Human cystatin C: A new biomarker of idiopathic pulmonary fibrosis? , 2014, Proteomics. Clinical applications.

[6]  Maelíosa T. C. McCrudden,et al.  LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid. , 2013, Journal of clinical periodontology.

[7]  T. Livache,et al.  Binding of chondroitin 4-sulfate to cathepsin S regulates its enzymatic activity. , 2013, Biochemistry.

[8]  R. Veldhuizen,et al.  Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties. , 2013, The international journal of biochemistry & cell biology.

[9]  G. Lushington,et al.  Clinical Relevance of Cathelicidin in Infectious Disease , 2013 .

[10]  M. Pazgier,et al.  Structural and functional analysis of the pro-domain of human cathelicidin, LL-37. , 2013, Biochemistry.

[11]  Liliane Schoofs,et al.  A comprehensive summary of LL-37, the factotum human cathelicidin peptide. , 2012, Cellular immunology.

[12]  J. Bang,et al.  Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37 , 2012, Peptides.

[13]  A. Szymańska,et al.  Human Cysteine Cathepsins Are Not Reliable Markers of Infection by Pseudomonas aeruginosa in Cystic Fibrosis , 2011, PloS one.

[14]  J. Sage,et al.  Cysteine Cathepsins: Markers and Therapy Targets in Lung Disorders , 2011 .

[15]  Yen Sun,et al.  Transmembrane pores formed by human antimicrobial peptide LL-37. , 2011, Biophysical journal.

[16]  R. Gallo,et al.  Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. , 2010, The Journal of investigative dermatology.

[17]  M. Rapala-Kozik,et al.  Proteolytic Inactivation of LL-37 by Karilysin, a Novel Virulence Mechanism of Tannerella forsythia , 2010, Journal of Innate Immunity.

[18]  M. Benincasa,et al.  Activity of antimicrobial peptides in the presence of polysaccharides produced by pulmonary pathogens , 2009, Journal of peptide science : an official publication of the European Peptide Society.

[19]  N. McElvaney,et al.  LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline1 , 2009, The Journal of Immunology.

[20]  M. Yazdanbakhsh,et al.  Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses , 2009, Biological chemistry.

[21]  A. Schmidtchen,et al.  Evaluation of Strategies for Improving Proteolytic Resistance of Antimicrobial Peptides by Using Variants of EFK17, an Internal Segment of LL-37 , 2008, Antimicrobial Agents and Chemotherapy.

[22]  P. Janmey,et al.  Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. , 2008, The Journal of antimicrobial chemotherapy.

[23]  F. Veillard,et al.  Lung cysteine cathepsins: intruders or unorthodox contributors to the kallikrein-kinin system? , 2008, The international journal of biochemistry & cell biology.

[24]  Shunyi Zhu,et al.  Activation of cathepsin L by the cathelin-like domain of protegrin-3. , 2008, Molecular immunology.

[25]  P. Janmey,et al.  Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum , 2007, European Respiratory Journal.

[26]  E. Purisima,et al.  The S2 subsites of cathepsins K and L and their contribution to collagen degradation , 2007, Protein science : a publication of the Protein Society.

[27]  D. Brömme,et al.  Modulation of hypotensive effects of kinins by cathepsin K. , 2007, Archives of biochemistry and biophysics.

[28]  P. Hiemstra THE ROLE OF EPITHELIAL β-DEFENSINS AND CATHELICIDINS IN HOST DEFENSE OF THE LUNG , 2007 .

[29]  Francesco Leonetti,et al.  Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities* , 2006, Journal of Biological Chemistry.

[30]  T. Kirikae,et al.  Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. , 2005, Chest.

[31]  K. Rabe,et al.  The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. , 2005, Pulmonary pharmacology & therapeutics.

[32]  E. Purisima,et al.  Inhibition of a cathepsin L-like cysteine protease by a chimeric propeptide-derived inhibitor. , 2005, Biochemistry.

[33]  M. Benincasa,et al.  Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens , 2005, Peptides.

[34]  R. Gallo,et al.  Structure-Function Relationships among Human Cathelicidin Peptides: Dissociation of Antimicrobial Properties from Host Immunostimulatory Activities , 2005, The Journal of Immunology.

[35]  W. Shafer,et al.  Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases , 2004, Antimicrobial Agents and Chemotherapy.

[36]  N. McElvaney,et al.  Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. , 2004, The Journal of infectious diseases.

[37]  R. Suvanasuthi,et al.  Proteus mirabilis ZapA Metalloprotease Degrades a Broad Spectrum of Substrates, Including Antimicrobial Peptides , 2004, Infection and Immunity.

[38]  Sandor Vajda,et al.  ClusPro: a fully automated algorithm for protein-protein docking , 2004, Nucleic Acids Res..

[39]  U. Wahn,et al.  β-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis , 2004 .

[40]  V. Nizet,et al.  Endogenous production of antimicrobial peptides in innate immunity and human disease , 2003, Current allergy and asthma reports.

[41]  R. Levine,et al.  Inactivation of Human β-Defensins 2 and 3 by Elastolytic Cathepsins1 , 2003, The Journal of Immunology.

[42]  P. Janmey,et al.  The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. , 2003, American journal of respiratory cell and molecular biology.

[43]  V. Nizet,et al.  Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. , 2003, The Journal of investigative dermatology.

[44]  A. Schmidtchen,et al.  Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37 , 2002, Molecular microbiology.

[45]  R. Hancock,et al.  The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1 , 2002, The Journal of Immunology.

[46]  R. Levine,et al.  Cathepsin B, L, and S Cleave and Inactivate Secretory Leucoprotease Inhibitor* , 2001, The Journal of Biological Chemistry.

[47]  R. Bals,et al.  Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid. , 2001, American journal of respiratory cell and molecular biology.

[48]  J. Calafat,et al.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. , 2001, Blood.

[49]  K. Berndt,et al.  Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37* , 1998, The Journal of Biological Chemistry.

[50]  James M. Wilson,et al.  Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis , 1997, Cell.

[51]  R. Ménard,et al.  Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. , 1996, The EMBO journal.

[52]  E. Greenberg,et al.  Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid , 1996, Cell.

[53]  F. Gauthier,et al.  Inhibition of rat tissue kallikrein gene family members by rat kallikrein‐binding protein and α1‐proteinase inhibitor , 1992, FEBS letters.

[54]  R. Jackson,et al.  Ultrasensitive assays for endogenous antimicrobial polypeptides. , 1991, Journal of immunological methods.

[55]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[56]  P. Hiemstra The role of epithelial beta-defensins and cathelicidins in host defense of the lung. , 2007, Experimental lung research.

[57]  J. van Marle,et al.  The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans , 2006, Biological chemistry.